#2537 - David Sinclair

Longevity science is entering a transformative era where aging is increasingly viewed as a reversible condition rather than an inevitable decline. Dr. David Sinclair, a Harvard researcher, details breakthroughs in epigenetic reprogramming using OSK genes to "reboot" cellular function, effectively restoring youthful identity to aged cells. Human clinical trials are currently underway, utilizing viral delivery systems to treat age-related vision loss like glaucoma. Beyond genetic interventions, the conversation emphasizes the critical role of lifestyle protocols—such as intermittent fasting, resistance training, and cold exposure—in triggering hormetic stress responses that bolster health. Furthermore, AI-driven drug discovery is drastically accelerating the identification of therapeutic molecules, potentially shortening research timelines from decades to months. Ultimately, maintaining robust blood flow, managing chronic stress, and fostering strong social relationships remain foundational pillars for extending human health span and vitality.